TrialThe European respiratory journal2018

The short-term bronchodilator effects of the dual phosphodiesterase 3 and 4 inhibitor RPL554 in COPD.

Dave Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.